During the last session, SELLAS Life Sciences Group Inc (NASDAQ:SLS)’s traded shares were 1.31 million, with the beta value of the company hitting 2.18. At the end of the trading day, the stock’s price was $1.54, reflecting an intraday loss of -5.52% or -$0.09. The 52-week high for the SLS share is $1.91, that puts it down -24.03 from that peak though still a striking 67.53% gain since the share price plummeted to a 52-week low of $0.50. The company’s market capitalization is $86.66M, and the average trade volume was 1.45 million shares over the past three months.
SELLAS Life Sciences Group Inc (NASDAQ:SLS) trade information
SELLAS Life Sciences Group Inc (SLS) registered a -5.52% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -5.52% in intraday trading to $1.54, hitting a weekly high. The stock’s 5-day price performance is 9.22%, and it has moved by 48.08% in 30 days. Based on these gigs, the overall price performance for the year is 14.07%.
SELLAS Life Sciences Group Inc (SLS) estimates and forecasts
Statistics show that SELLAS Life Sciences Group Inc has outperformed its competitors in share price, compared to the industry in which it operates. SELLAS Life Sciences Group Inc (SLS) shares have gone up 71.49% during the last six months, with a year-to-date growth rate more than the industry average at 35.07% against 12.90. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 55.30% this quarter and then jump 35.50% in the quarter after that.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 61.44%. While earnings are projected to return 14.93% in 2024.
SLS Dividends
SELLAS Life Sciences Group Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
